Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

NATTO: ENHANCED MANAGEMENT STRUCTURE ALIGNED WITH FOCUSED BUSINESS UNIT STRATEGY

Current NattoPharma CEO appointed to Interim CEO of PharmaCo. Current CFO to take on additional role as Interim CEO of NattoPharma. Additional resources and capabilities are added to NattoPharma sales and supply chain functions.Oslo, Norway (8th February 2018) - Following the PharmaCo spin-off, Daniel Rosenbaum, current CEO of NattoPharma will be seconded to PharmaCo in order to assure an effective transition and immediate start-up of PharmaCo critical operations. During this period Mr. Rosenbaum will serve as the Interim CEO while the newly formed Board of Directors of PharmaCo AS works to

NATTO: SECOND HALF AND PRELIMINARY FULL YEAR 2017 EARNINGS RELEASE

Oslo, Norway (8th February 2018) - Please find attached the Nattopharma Group Second Half and Preliminary Full Year 2017 Earnings Release. Financial highlights of 2017 are; · Record sales of NOK 66,6 million full year and 36,0 million H2 · Positive Adj. EBITDA NOK 5,3 million full year and 3,8 million H2 · Significantly improved product margin: · o   49% in H2-2017 vs 41,6% in H2-2016 · Operating improvement increasing momentum in Q4 · Positive Net Result of NOK 22,9 million full year and 30,0 million H2  A presentation will be held via webcast by Dan Rosenbaum

Update on Tawke PSC

8 February 2018 Genel Energy plc Update on Tawke PSC Genel Energy plc ('Genel') notes that DNO ASA, as operator of the Tawke PSC (Genel 25%working interest), has today issued the following update on licence activity. Two wells are currently producing a total of 16,000 bopd at the Peshkabir field, which are commingled for export with another 97,000 bopd from the Tawke field, on the same license. A total of six Peshkabir wells are planned to be drilled this year, and field production is expected by the operator to reach 30,000 bopd by summer and continue to ramp up in the

Waystream continues to grow in the Danish market- Energi Fyn acquires access equipment worth SEK 6 million

The new order includes access equipment in the form of Waystream ASR6000 and associated SFP (media converter). The order will be delivered immediately and will be used for new construction and upgrading of existing networks at Energi Fyn Bredbånd. "We are proud to be part of Energi Fyn Bredbånd's ambitious fiber initiative. It is always especially fun with repeat customers because it confirms that our products and services create great value, "says Mats Öberg, CEO of Waystream.  Fibernet is the fastest growing broadband technology in Denmark. According to the Danish Energy Agency's

Year-end report January - December 2017

High growth rate and significantly improved resultFourth quarter October – December 2017 · Net sales amounted to 188.9 MSEK (179.1), which is an increase by 5.4 percent compared to the corresponding quarter last year. At comparable exchange rates[1] net sales increased by 7.1 percent. · Operating profit increased by 34 percent to 32.3 MSEK (24.1). · Result after tax increased by 98 percent to 34.6 MSEK (17.5). · Earnings per share amounted to 0.54 SEK (0.27) before and after dilution. · The cash flow from operating activities increased to 66.2 MSEK (42.4). · Net cash[1]

Another patent approval in the US related to Episurf Medical’s 3D-based damage assessment tool

Episurf Medical has received another Notice of Allowance from the United States Patent and Trademark Office (USPTO). The patent being approved is within the area of 3D-based assessment of joint lesions, and complements Episurf Medical’s first US patent approval within that field, received in 2017. “This patent covers important parts of our technology in the exciting field of medical imaging, where we are continuously working with protection of our intellectual properties” comments Pål Ryfors, CEO, Episurf Medical.   For more  information, please contact: Pål Ryfors, CEO, Episurf

Report on operations 2017: Continued profitable growth

Fourth quarter: ·  Sales amounted to SEK 271 (251) million, corresponding to an increase of 8 percent in SEK. Sales growth was 11 percent in local currency and consisted in its entirety of organic growth. ·  Operating income before depreciation and amortisation (EBITDA) amounted to SEK 103 (96) million, corresponding to a margin of 38 (38) percent. Fluctuations in exchange rates negatively impacted EBITDA by SEK 5 million. ·  Net income amounted to SEK 69 (60) million, which gave earnings per share of SEK 3.15 (2.74). Whole year 2017: ·  Sales amounted to SEK 1 046 (856)

Invitation to conference call, February 15 at 2:30 pm CET

Studsvik AB presents its Year-end Report for 2017 and hereby invites media and analysts to a conference call held in English on Thursday, February 15 at 2:30 pm CET.Studsvik’s Year-end Report for 2017 will be distributed at approximately 13.00 pm CET, February 15. As of this time, the report will also be available at www.studsvik.com. The call will be held in English, starting 2:30 pm CET. Please call at least ten minutes prior to the start of the conference call to avoid delay. Event title is: Studsvik Q4 2017. Conference ID is: 3280859 Description Local Call Dial-In Numbers

The Board of Directors of Konecranes Plc decided to continue the Employee Share Savings Plan

KONECRANES PLC  STOCK EXCHANGE RELEASE  February 8, 2018  at 9:30 EETThe Board of Directors of Konecranes Plc decided to continue the Employee Share Savings PlanKonecranes Plc’s Annual General Meeting of Shareholders 2012 decided to implement an Employee Share Savings Plan (the Plan) in the Konecranes Group.On the basis of interest shown by the Group employees, the Board has decided to launch a new Plan Period. The new plan period will begin on July 1, 2018 and end on June 30, 2019. The maximum savings amount per participant during one month is 5 percent of gross salary and the

Passenger record for Swedavia’s airports in January

More than 2,900,000 passengers flew to or from Swedavia’s airports in January 2018, which is a 2 per cent increase compared to the same month in 2017. International passenger volume was up more than 3 per cent to over 1,900,000 passengers. Domestic passenger volume was essentially on the same level as in 2017, at 1,006,000 passengers. Stockholm Arlanda Airport saw a 2 per cent increase to more than 1,800,000 passengers. Volume at Göteborg Landvetter Airport rose 2 per cent to more than 450,000 passengers and volume at Bromma Stockholm Airport rose 3 per cent to 185,000 passengers. At

Raisio plc: Raisio's converted shares

Raisio plc      Stock Exchange Release, 8 February 2018 RAISIO'S CONVERTED SHARES The Board of Directors of Raisio plc has decided in its meeting held on 25 January 2018 to convert a total of 221,121 restricted shares (series K) into free shares (series V). The decision has been entered in the Trade Register today, on 8 February 2018. The additional lot of free shares in question is admitted to trading on the Nasdaq Helsinki Ltd as of 9 February 2018. Since the beginning of 2018, a total of 221,121 restricted shares of the company have been converted into free shares. The number of

Konecranes Plc’s Board of Directors convenes Annual General Meeting 2018

KONECRANES PLC  STOCK EXCHANGE RELEASE  February 8, 2018 at 09.15 a.m. EETKonecranes Plc’s Board of Directors convenes Annual General Meeting 2018Notice to the General Meeting Notice is given to the shareholders of Konecranes Plc to the Annual General Meeting to be held on Tuesday 27 March 2018 at 10.00 a.m. at Hyvinkääsali (address: Jussinkuja 1, 05800 Hyvinkää, Finland). Reception of persons registered for the meeting and distribution of voting tickets will commence at 9.15 a.m. A. Matters on the agenda of the General Meeting At the General Meeting, the following matters will

Acando Year-end report 2017

Third quarter October 1–December 31, 2017 · Net sales totaled SEK 693 m (633) · Operating profit amounted to SEK 87 m (82) · The operating margin was 12.5% (12.9) · Profit after tax was SEK 67 m (67) · Earnings per share were SEK 0.64 (0.65) Accumulated January 1–December 31, 2017 · Net sales totaled SEK 2,444 m (2,206) · Operating profit amounted to SEK 243 m (210) · The operating margin was 10.0% (9.5) · Profit after tax was SEK 180 m (180) · Earnings per share were SEK 1.73 (1.75) · Cash and cash equivalents tot SEK 90 m (72) · The Board intends

Boozt.com enters agreement with adidas and Reebok

Boozt.com, one of Nordic’s leading online fashion retailers, has entered into an agreement with adidas and Reebok to sell their products on Boozt.com. The agreement contains Reebok Classic and adidas Originals lifestyle collections of footwear, apparel and accessories. In addition, Boozt.com will be selling a curated selection of adidas and Reebok Sport Performance products including footwear, apparel and accessories.Hermann Haraldsson, CEO at Boozt AB, says: “We are proud to be able to offer strong brands like adidas & Reebok to our customers. It will significantly strengthen our

Interim Report January-December 2017

Strong result with continued good growth”The fourth quarter was eventful, we delivered strong results with a good growth rate, and at the same time we launched a new strategy and direction for ÅF. These results, together with the new strategic direction and increasing demand for ÅF’s solutions, form the foundation for continued profitable growth in 2018,” said Jonas Gustavsson, President and CEO. Fourth quarter 2017 · Net sales amounted to SEK 3,500 million (3,138) · EBITA totalled SEK 344 million (306) · EBITA margin was 9.8 percent (9.7) · EBIT (operating profit) was SEK

BioGaia AB – Year-end report 2017

Comments from the Managing Director: “2017 was yet another successful year for BioGaia. With growth of 15%, we were able to boost our sales by SEK 80 million and achieve an annual turnover of SEK 615 million. We have thus continued our excellent trend of expanding our share of a market that is expected to grow by around 7% annually. Our operating profit exceeded 200 million for the first time and reached SEK 234 million, an increase of 17% that resulted in an operating margin of 38%. With the proof at hand, it is clear that we have very successfully managed to combine our development

REPORT ON THE FOURTH QUARTER 2017

FOURTH QUARTER · Net sales totaled SEK 3,252 million (2,786); an increase of 17%, of which 16% was organic growth. · Operating profit (EBIT) before items affecting comparability amounted to SEK 310 million (210), representing a margin of 9.5% (7.5%), including a net positive effect of SEK 17 million relating to the US class action legal cases of which SEK 28 million was reimbursement. · Operating profit (EBIT) amounted to SEK 191 million (173), including items affecting comparability amounting to SEK -119 million, related to SeaStar Solutions transaction costs and the EMEA

Citycon’s Financial Statements and Corporate Governance Statement for 2017 published

CITYCON OYJ   Stock Exchange Release   8 February 2017 at 09:00 hrsCitycon Oyj’s Financial Review for 2017 has been published today. The Financial Review includes the Report by the Board of Directors, Consolidated Financial Statements, Parent Company Financial Statements and Auditor’s Report for the accounting period 1 January – 31 December 2017.Citycon Oyj has also published its Corporate Governance Statement 2017. The statement is prepared in accordance with the recommendations of the Finnish Corporate Governance Code published by the Finnish Securities Market Association.The

Citycon Board’s asset distribution proposal to the Annual General Meeting

CITYCON OYJ   Stock Exchange Release   8 February 2018 at 09:00 hrsThe Board of Directors of Citycon Oyj has decided to propose to the Annual General Meeting to be held on 20 March 2018 of the asset distribution as follows.The Board of Directors proposes that based on the balance sheet to be adopted for the financial period ended on 31 December 2017, no dividend is distributed by a resolution of the Annual General Meeting.Nonetheless, the Board of Directors proposes that the Board of Directors be authorized to decide in its discretion on the distribution of dividend and assets from the

Invitation to presentation of Humana’s fourth quarter report 2017

Humana’s interim report for the fourth quarter 2017 will be published at 08:00 CET on February 21, 2018. A web-cast telephone conference will be held at 09:00 CET the same day, where CEO and President Rasmus Nerman and CFO Ulf Bonnevier will present the results for the fourth quarter 2017.A possibility will be given to ask questions via the webcast and follow the presentation material live. The webcast, which afterwards also will be available on demand, will be accessible at Humana’s financial website, http://corporate.humana.se. The presentation and webcast is also available on www.

Crystal Magic at Ambiente!

Kosta Boda kicks off the 2018 Ambiente Fair with the introduction of the exciting collaborations – Crystal Magic, an elegant drinking glass series by the pioneering Åsa Jungnelius.Last year, Kosta Boda celebrated its 275th anniversary with a regal event in Kosta on 6 June with HRH the King and HRH Queen Sylvia, as well as the widely acclaimed tribute exhibition Hommage, for which Åsa were invited to contribute their own innovations. The design objects created especially for Hommage have infused Kosta Boda with new energy, inspiration and fire, but above all they’ve re-established the

Nokian Tyres plc: Shares subscribed with option rights

Nokian Tyres plc  Total number of voting rights and capital   February 8, 2018, 9.00 a.m. After December 21, 2017 registered new shares a total of 10,370 Nokian Tyres plc's shares have been subscribed with the 2013B option rights and a total of 120 shares with the 2013C option rights. These option rights are attached to the Nokian Tyres plc's Option Program of 2013. New shares have been registered into the Trade Register on February 8, 2018, as of which date the new shares will establish shareholder rights. The share capital will not increase with subscriptions made by 2013 option

Isofol reports successful outcome from the scientific advice with the EMA

Isofol Medical AB (publ) has received positive feedback in scientific advice from the European Medicines Agency (EMA) regarding its candidate drug arfolitixorin (Modufolin®) intended for the treatment of advanced colorectal (colon) cancer. Thereby the significant parameters for the pivotal phase III study has been agreed upon with both the EMA and the FDA for the Marketing Authorisation Application (MAA) and a New Drug Application (NDA) for arfolitixorin (Modufolin®).The recent successful outcome of the scientific advice from the EMA and the successful completion of the End-of-Phase II (

There are no items matching the current filter
There are no more items matching the current filter
Back to top